BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34529108)

  • 21. The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.
    Kim Y; Wen X; Bae JM; Kim JH; Cho NY; Kang GH
    Histopathology; 2018 Oct; 73(4):663-671. PubMed ID: 29906313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of immunoscore related markers in bladder cancer.
    Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z
    BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in situ local immune response, tumour senescence and proliferation in colorectal cancer.
    Roxburgh CS; Richards CH; Macdonald AI; Powell AG; McGlynn LM; McMillan DC; Horgan PG; Edwards J; Shiels PG
    Br J Cancer; 2013 Oct; 109(8):2207-16. PubMed ID: 24022192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
    Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
    Front Immunol; 2019; 10():2936. PubMed ID: 31921188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
    Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
    Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer.
    Zadka Ł; Chabowski M; Grybowski D; Piotrowska A; Dzięgiel P
    Cancer Immunol Immunother; 2021 Sep; 70(9):2681-2700. PubMed ID: 33625532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simplified and Optimized Immune Score for Colorectal Cancer Microenvironment.
    Nakane H; Sudo T; Kawahara A; Yomoda T; Shigaki T; Fujiyoshi K; Ohchi T; Koushi K; Yoshida T; Ogata T; Fujita F; Akagi Y
    Anticancer Res; 2023 Aug; 43(8):3793-3798. PubMed ID: 37500158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival.
    Nagorsen D; Voigt S; Berg E; Stein H; Thiel E; Loddenkemper C
    J Transl Med; 2007 Nov; 5():62. PubMed ID: 18047662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
    Campbell MJ; Baehner F; O'Meara T; Ojukwu E; Han B; Mukhtar R; Tandon V; Endicott M; Zhu Z; Wong J; Krings G; Au A; Gray JW; Esserman L
    Breast Cancer Res Treat; 2017 Jan; 161(1):17-28. PubMed ID: 27785654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.
    Lalos A; Tülek A; Tosti N; Mechera R; Wilhelm A; Soysal S; Daester S; Kancherla V; Weixler B; Spagnoli GC; Eppenberger-Castori S; Terracciano L; Piscuoglio S; von Flüe M; Posabella A; Droeser RA
    Sci Rep; 2021 Jan; 11(1):775. PubMed ID: 33436863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological differences between colorectal cancer and normal mucosa uncover a prognostically relevant immune cell profile.
    Strasser K; Birnleitner H; Beer A; Pils D; Gerner MC; Schmetterer KG; Bachleitner-Hofmann T; Stift A; Bergmann M; Oehler R
    Oncoimmunology; 2019; 8(2):e1537693. PubMed ID: 30713795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer.
    Fujiyoshi K; Väyrynen JP; Borowsky J; Papke DJ; Arima K; Haruki K; Kishikawa J; Akimoto N; Ugai T; Lau MC; Gu S; Shi S; Zhao M; Da Silva AFL; Twombly TS; Nan H; Meyerhardt JA; Song M; Zhang X; Wu K; Chan AT; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    EBioMedicine; 2020 Jul; 57():102860. PubMed ID: 32652320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients.
    De Logu F; Galli F; Nassini R; Ugolini F; Simi S; Cossa M; Miracco C; Gianatti A; De Giorgi V; Rulli E; Cossu A; Massi D; Mandalà M
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages.
    Silva-Figueroa A; Villalobos P; Williams MD; Bassett RL; Clarke CN; Lee JE; Busaidy NL; Perrier ND
    Surgery; 2018 Nov; 164(5):960-964. PubMed ID: 30033186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.
    Walsh MD; Dent OF; Young JP; Wright CM; Barker MA; Leggett BA; Bokey L; Chapuis PH; Jass JR; Macdonald GA
    Int J Cancer; 2009 Sep; 125(5):1231-7. PubMed ID: 19462453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
    Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
    Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Analysis of Immune Infiltrates in Primary Melanoma.
    Gartrell RD; Marks DK; Hart TD; Li G; Davari DR; Wu A; Blake Z; Lu Y; Askin KN; Monod A; Esancy CL; Stack EC; Jia DT; Armenta PM; Fu Y; Izaki D; Taback B; Rabadan R; Kaufman HL; Drake CG; Horst BA; Saenger YM
    Cancer Immunol Res; 2018 Apr; 6(4):481-493. PubMed ID: 29467127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
    Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
    Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.